APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostacyclin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026187 pages

Choose your research edition.

Industry ResearchProstacyclin Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Prostacyclin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prostacyclin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostacyclin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostacyclin Drug include Teva, GSK, Bayer AG, United Therapeutics, Toray, Tide Pharma and Actelion (J & J), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostacyclin Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostacyclin Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostacyclin Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostacyclin Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostacyclin Drug Segment by Company

Teva

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Actelion (J & J)

Prostacyclin Drug Segment by Type

Beraprost Sodium

Epoprostenol Sodium

Treprostinil

Iloprost

Prostacyclin Drug Segment by Application

For Injection

For Inhalation

For Oral

Prostacyclin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostacyclin Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostacyclin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostacyclin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostacyclin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostacyclin Drug Industry Trends Table 2. Prostacyclin Drug Industry Drivers Table 3. Prostacyclin Drug Industry Opportunities and Challenges Table 4. Prostacyclin Drug Industry Restraints Table 5. Global Prostacyclin Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostacyclin Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostacyclin Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Prostacyclin Drug Sales Market Share by Manufacturers Table 9. Global Prostacyclin Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Prostacyclin Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostacyclin Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostacyclin Drug Manufacturers, Product Type & Application Table 13. Global Prostacyclin Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostacyclin Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Beraprost Sodium Table 17. Major Manufacturers of Epoprostenol Sodium Table 18. Major Manufacturers of Treprostinil Table 19. Major Manufacturers of Iloprost Table 20. Global Prostacyclin Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Prostacyclin Drug Sales Market Share by Type (2021-2026) Table 24. Global Prostacyclin Drug Sales Market Share by Type (2027-2032) Table 25. Global Prostacyclin Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Prostacyclin Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Prostacyclin Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Prostacyclin Drug Revenue Market Share by Type (2021-2026) Table 29. Global Prostacyclin Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of For Injection Table 31. Major Manufacturers of For Inhalation Table 32. Major Manufacturers of For Oral Table 33. Global Prostacyclin Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 35. Global Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 36. Global Prostacyclin Drug Sales Market Share by Application (2021-2026) Table 37. Global Prostacyclin Drug Sales Market Share by Application (2027-2032) Table 38. Global Prostacyclin Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Prostacyclin Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global Prostacyclin Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global Prostacyclin Drug Revenue Market Share by Application (2021-2026) Table 42. Global Prostacyclin Drug Revenue Market Share by Application (2027-2032) Table 43. Global Prostacyclin Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Prostacyclin Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Prostacyclin Drug Sales Market Share by Region (2021-2026) Table 46. Global Prostacyclin Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Prostacyclin Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 50. North America Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Prostacyclin Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Prostacyclin Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Prostacyclin Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Prostacyclin Drug Revenue Market Share by Region (2021-2026) Table 64. Global Prostacyclin Drug Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Prostacyclin Drug Product Portfolio Table 69. Teva Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GSK Prostacyclin Drug Product Portfolio Table 74. GSK Recent Development Table 75. Bayer AG Company Information Table 76. Bayer AG Business Overview Table 77. Bayer AG Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bayer AG Prostacyclin Drug Product Portfolio Table 79. Bayer AG Recent Development Table 80. United Therapeutics Company Information Table 81. United Therapeutics Business Overview Table 82. United Therapeutics Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. United Therapeutics Prostacyclin Drug Product Portfolio Table 84. United Therapeutics Recent Development Table 85. Toray Company Information Table 86. Toray Business Overview Table 87. Toray Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Toray Prostacyclin Drug Product Portfolio Table 89. Toray Recent Development Table 90. Tide Pharma Company Information Table 91. Tide Pharma Business Overview Table 92. Tide Pharma Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Tide Pharma Prostacyclin Drug Product Portfolio Table 94. Tide Pharma Recent Development Table 95. Actelion (J & J) Company Information Table 96. Actelion (J & J) Business Overview Table 97. Actelion (J & J) Prostacyclin Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Actelion (J & J) Prostacyclin Drug Product Portfolio Table 99. Actelion (J & J) Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Prostacyclin Drug Distributors List Table 103. Prostacyclin Drug Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Prostacyclin Drug Product Image Figure 2. Global Prostacyclin Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostacyclin Drug Sales (2021-2032) & (K Units) Figure 5. Global Prostacyclin Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostacyclin Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Beraprost Sodium Image Figure 9. Epoprostenol Sodium Image Figure 10. Treprostinil Image Figure 11. Iloprost Image Figure 12. Global Prostacyclin Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Prostacyclin Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Prostacyclin Drug Sales Market Share by Type (2021-2032) Figure 15. Global Prostacyclin Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Prostacyclin Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Prostacyclin Drug Revenue Market Share by Type (2021-2032) Figure 18. For Injection Image Figure 19. For Inhalation Image Figure 20. For Oral Image Figure 21. Global Prostacyclin Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Prostacyclin Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prostacyclin Drug Sales Market Share by Application (2021-2032) Figure 24. Global Prostacyclin Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Prostacyclin Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Prostacyclin Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Prostacyclin Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Prostacyclin Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Prostacyclin Drug Sales Market Share by Country (2021-2032) Figure 41. China Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Prostacyclin Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Prostacyclin Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Prostacyclin Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Prostacyclin Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prostacyclin Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prostacyclin Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Beraprost Sodium
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
Applications
  • For Injection
  • For Inhalation
  • For Oral
Companies covered
  • Teva
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma
  • Actelion (J & J)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostacyclin Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostacyclin Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostacyclin Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostacyclin Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostacyclin Drug Market Dynamics
  1. 2.1 Prostacyclin Drug Industry Trends
  2. 2.2 Prostacyclin Drug Industry Drivers
  3. 2.3 Prostacyclin Drug Industry Opportunities and Challenges
  4. 2.4 Prostacyclin Drug Industry Restraints
3 Prostacyclin Drug Market by Manufacturers
  1. 3.1 Global Prostacyclin Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostacyclin Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostacyclin Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostacyclin Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostacyclin Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostacyclin Drug Manufacturers, Product Type & Application
  7. 3.7 Global Prostacyclin Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostacyclin Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostacyclin Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostacyclin Drug Tier 1, Tier 2, and Tier 3
4 Prostacyclin Drug Market by Type
  1. 4.1 Prostacyclin Drug Type Introduction
  2. 4.1.1 Beraprost Sodium
  3. 4.1.2 Epoprostenol Sodium
  4. 4.1.3 Treprostinil
  5. 4.1.4 Iloprost
  6. 4.2 Global Prostacyclin Drug Sales by Type
  7. 4.2.1 Global Prostacyclin Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prostacyclin Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Prostacyclin Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Prostacyclin Drug Revenue by Type
  11. 4.3.1 Global Prostacyclin Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prostacyclin Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Prostacyclin Drug Revenue Market Share by Type (2021-2032)
5 Prostacyclin Drug Market by Application
  1. 5.1 Prostacyclin Drug Application Introduction
  2. 5.1.1 For Injection
  3. 5.1.2 For Inhalation
  4. 5.1.3 For Oral
  5. 5.2 Global Prostacyclin Drug Sales by Application
  6. 5.2.1 Global Prostacyclin Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostacyclin Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Prostacyclin Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prostacyclin Drug Revenue by Application
  10. 5.3.1 Global Prostacyclin Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prostacyclin Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Prostacyclin Drug Revenue Market Share by Application (2021-2032)
6 Global Prostacyclin Drug Sales by Region
  1. 6.1 Global Prostacyclin Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostacyclin Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Prostacyclin Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Prostacyclin Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostacyclin Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostacyclin Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostacyclin Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostacyclin Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostacyclin Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostacyclin Drug Revenue by Region
  1. 7.1 Global Prostacyclin Drug Revenue by Region
  2. 7.1.1 Global Prostacyclin Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostacyclin Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostacyclin Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostacyclin Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostacyclin Drug Revenue (2021-2032)
  8. 7.2.2 North America Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostacyclin Drug Revenue (2021-2032)
  11. 7.3.2 Europe Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostacyclin Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostacyclin Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostacyclin Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Prostacyclin Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Prostacyclin Drug Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Bayer AG
  14. 8.3.1 Bayer AG Company Information
  15. 8.3.2 Bayer AG Business Overview
  16. 8.3.3 Bayer AG Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer AG Prostacyclin Drug Product Portfolio
  18. 8.3.5 Bayer AG Recent Developments
  19. 8.4 United Therapeutics
  20. 8.4.1 United Therapeutics Company Information
  21. 8.4.2 United Therapeutics Business Overview
  22. 8.4.3 United Therapeutics Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 United Therapeutics Prostacyclin Drug Product Portfolio
  24. 8.4.5 United Therapeutics Recent Developments
  25. 8.5 Toray
  26. 8.5.1 Toray Company Information
  27. 8.5.2 Toray Business Overview
  28. 8.5.3 Toray Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Toray Prostacyclin Drug Product Portfolio
  30. 8.5.5 Toray Recent Developments
  31. 8.6 Tide Pharma
  32. 8.6.1 Tide Pharma Company Information
  33. 8.6.2 Tide Pharma Business Overview
  34. 8.6.3 Tide Pharma Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tide Pharma Prostacyclin Drug Product Portfolio
  36. 8.6.5 Tide Pharma Recent Developments
  37. 8.7 Actelion (J & J)
  38. 8.7.1 Actelion (J & J) Company Information
  39. 8.7.2 Actelion (J & J) Business Overview
  40. 8.7.3 Actelion (J & J) Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Actelion (J & J) Prostacyclin Drug Product Portfolio
  42. 8.7.5 Actelion (J & J) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostacyclin Drug Value Chain Analysis
  2. 9.1.1 Prostacyclin Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostacyclin Drug Production Mode & Process
  6. 9.2 Prostacyclin Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostacyclin Drug Distributors
  9. 9.2.3 Prostacyclin Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst